Insufficient scRNA-seq data for expression of DOLK at single-cell level.
Insufficient scRNA-seq data for expression of DOLK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 643.03 | 328 / 328 | 100% | 29.83 | 178 / 178 |
prostate | 100% | 732.07 | 245 / 245 | 100% | 55.04 | 502 / 502 |
skin | 100% | 955.47 | 1809 / 1809 | 100% | 42.06 | 471 / 472 |
uterus | 100% | 769.24 | 170 / 170 | 100% | 35.46 | 458 / 459 |
thymus | 100% | 728.37 | 653 / 653 | 100% | 38.29 | 603 / 605 |
breast | 100% | 775.47 | 459 / 459 | 99% | 41.87 | 1112 / 1118 |
esophagus | 99% | 705.70 | 1436 / 1445 | 100% | 31.68 | 183 / 183 |
kidney | 100% | 612.93 | 89 / 89 | 99% | 27.47 | 895 / 901 |
intestine | 100% | 657.67 | 964 / 966 | 99% | 33.79 | 524 / 527 |
adrenal gland | 100% | 1353.63 | 258 / 258 | 99% | 37.23 | 228 / 230 |
liver | 99% | 547.53 | 224 / 226 | 100% | 30.31 | 406 / 406 |
bladder | 100% | 643.19 | 21 / 21 | 99% | 32.81 | 498 / 504 |
stomach | 99% | 772.57 | 357 / 359 | 99% | 32.45 | 284 / 286 |
brain | 99% | 488.01 | 2605 / 2642 | 100% | 48.69 | 705 / 705 |
lung | 99% | 776.14 | 570 / 578 | 100% | 34.73 | 1152 / 1155 |
ovary | 98% | 544.56 | 176 / 180 | 100% | 32.70 | 430 / 430 |
adipose | 100% | 813.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 45.17 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.35 | 29 / 29 |
spleen | 100% | 764.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.86 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.19 | 1 / 1 |
blood vessel | 99% | 596.82 | 1322 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 472.39 | 831 / 861 | 0% | 0 | 0 / 0 |
muscle | 95% | 369.24 | 759 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 52% | 206.25 | 485 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006489 | Biological process | dolichyl diphosphate biosynthetic process |
GO_0043048 | Biological process | dolichyl monophosphate biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004168 | Molecular function | dolichol kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DOLK |
Protein name | Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15) dolichol kinase (EC 2.7.1.108) |
Synonyms | UNQ2422/PRO4980 KIAA1094 TMEM15 hCG_30591 |
Description | FUNCTION: Catalyzes CTP-mediated phosphorylation of dolichol, the terminal step in de novo dolichyl monophosphate (Dol-P) biosynthesis . Dol-P is a lipid carrier essential for the synthesis of N-linked and O-linked oligosaccharides and for GPI anchors . . |
Accessions | A0A0S2Z597 ENST00000372586.4 Q9UPQ8 A0A0S2Z5Y1 |